Clinical Trials Browser

Lymphoma, Extranodal NK-T-Cell × pembrolizumab × 90 days × Clear all

NCT04417166 2026-04-07

Pembrolizumab and Radiotherapy for Patients With NK/T Cell Lymphoma

Phase 2 Active not recruiting

Lymphoma, Extranodal NK-T-Cell